Facebook Pixel Code
About Sickkids
About SickKids

Anita Villani, MD, M.Sc.

The Hospital for Sick Children
Associate Staff Oncologist

Associate Director, SickKids Cancer Sequencing Program (KiCS)
Garron Family Cancer Centre

Research Institute
Project Investigator
Research Institute

University of Toronto
Assistant Professor
Department of Paaediatrics

Phone: 416-813-7654 ext. 204465
Fax: 416-813-5327
Email: anita.villani@sickkids.ca

For more information, visit:

Cancer Genetics website

Brief Biography

Dr. Anita Villani received her medical degree at the University of Ottawa. She completed both her paediatric residency training and haematology/oncology fellowship at The Hospital for Sick Children in Toronto. She went on to obtain her Master’s of Science degree in Genetics and Genome Biology through the Clinician Investigator Program and Institute of Medical Science at the University of Toronto. Her research took place in the laboratory of Dr. David Malkin, where she investigated genetic modifiers in the Li-Fraumeni Cancer susceptibility syndrome.  
Villani was appointed as an Associate Staff Oncologist in the Division of Haematology/Oncology at The Hospital for Sick Children in 2016 and an Assistant Professor in the Department of Paediatrics at the University of Toronto in 2017. She has a clinical and research interest in cancer genetics and predisposition, including the creation and evaluation of surveillance strategies for cancer-prone children, using both traditional and novel approaches. She has led and co-authored a number of primary research studies and guidelines on surveillance for children with cancer predisposition syndromes. Her work also aims to elucidate the unique aspects of cancer management in this patient population.  

Villani is the Associate Director of the SickKids Precision Oncology Research Program (“KiCS”) and focuses on the translational implementation of genomic technologies into clinical oncology care. She is interested in exploring the clinical utility of genomic findings, describing novel germline susceptibility genes and pathways, and exploring the ethics and the stakeholder experience of precision oncology research.

Research Interests

  • Surveillance in cancer predisposition syndromes
  • Prevention and management of malignant disease in cancer-prone individuals
  • Implementation of genomic technologies into clinical oncology care


  • Canadian Cancer Society’s Top 10 Society-funded research stories of 2016
  • Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarship (2014-2015)
  • Clinician Scientist Graduate Scholarship, Postgraduate Medical Education, University of Toronto (2014, 2015)
  • Institute of Medical Science (University of Toronto) Academic Development Award (2015)
  • CIHR Institute of Genetics – Lap-Chee Tsui Publication Prize (2011)


For a detailed list of Dr. Villani's publications, please visit PubMed.